These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
583 related items for PubMed ID: 11586471
1. Hepatic stellate cells as a target for the treatment of liver fibrosis. Bataller R, Brenner DA. Semin Liver Dis; 2001 Aug; 21(3):437-51. PubMed ID: 11586471 [Abstract] [Full Text] [Related]
5. Liver fibrosis: from the bench to clinical targets. Pinzani M, Rombouts K. Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333 [Abstract] [Full Text] [Related]
6. [Therapeutical targets for revert liver fibrosis]. García B L, Gálvez G J, Armendáriz B J. Rev Med Chil; 2007 Jun; 135(6):783-91. PubMed ID: 17728907 [Abstract] [Full Text] [Related]
7. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Friedman SL. Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):98-105. PubMed ID: 16265071 [Abstract] [Full Text] [Related]
9. Inhibitory effects of prostaglandin E1 on activation of hepatic stellate cells in rabbits with schistosomiasis. Zou WL, Yang Z, Zang YJ, Li DJ, Liang ZP, Shen ZY. Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):176-81. PubMed ID: 17374578 [Abstract] [Full Text] [Related]
10. [Liver fibrosis: pathophysiology, diagnosis and treatment]. Pár A, Pár G. Orv Hetil; 2005 Jan 02; 146(1):3-13. PubMed ID: 15715367 [Abstract] [Full Text] [Related]
11. Hepatic fibrosis -- overview. Friedman SL. Toxicology; 2008 Dec 30; 254(3):120-9. PubMed ID: 18662740 [Abstract] [Full Text] [Related]
12. Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic. Muddu AK, Guha IN, Elsharkawy AM, Mann DA. Int J Biochem Cell Biol; 2007 Dec 30; 39(4):695-714. PubMed ID: 17110155 [Abstract] [Full Text] [Related]
13. Wound healing and local neuroendocrine regulation in the injured liver. Ebrahimkhani MR, Elsharkawy AM, Mann DA. Expert Rev Mol Med; 2008 Apr 29; 10():e11. PubMed ID: 18442446 [Abstract] [Full Text] [Related]
14. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. Svegliati-Baroni G, De Minicis S, Marzioni M. Liver Int; 2008 Sep 29; 28(8):1052-64. PubMed ID: 18783548 [Abstract] [Full Text] [Related]
15. Stellate cell activation in alcoholic fibrosis--an overview. Friedman SL. Alcohol Clin Exp Res; 1999 May 29; 23(5):904-10. PubMed ID: 10371412 [Abstract] [Full Text] [Related]
16. Ribozymes against TGFbeta1 reverse character of activated hepatic stellate cells in vitro and inhibit liver fibrosis in rats. Song YH, Chen XL, Kong XJ, Liu NZ, Li W, Wu XL, Lin JS, Jin YX. J Gene Med; 2005 Jul 29; 7(7):965-76. PubMed ID: 15772939 [Abstract] [Full Text] [Related]
17. Gene regulation in hepatic stellate cell. Lang A, Brenner DA. Ital J Gastroenterol Hepatol; 1999 Mar 29; 31(2):173-9. PubMed ID: 10363203 [Abstract] [Full Text] [Related]
18. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. Guyot C, Lepreux S, Combe C, Doudnikoff E, Bioulac-Sage P, Balabaud C, Desmoulière A. Int J Biochem Cell Biol; 2006 Feb 29; 38(2):135-51. PubMed ID: 16257564 [Abstract] [Full Text] [Related]
19. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. Kisseleva T, Brenner DA. J Gastroenterol Hepatol; 2007 Jun 29; 22 Suppl 1():S73-8. PubMed ID: 17567473 [Abstract] [Full Text] [Related]
20. Hepatic stellate cells in inflammation-fibrosis-carcinoma axis. Wang BB, Cheng JY, Gao HH, Zhang Y, Chen ZN, Bian H. Anat Rec (Hoboken); 2010 Sep 29; 293(9):1492-6. PubMed ID: 20652939 [Abstract] [Full Text] [Related] Page: [Next] [New Search]